Conversely, a handful of genes in the LTS transcriptomic signature have been implicated in poorer prognosis in other cancers; these include EXOSC9 (breast cancer37), CNOT6 (osteosarcoma38), and RFC4 and PGRMC2 (numerous cancers39–42). This evidence concerns the gene PGRMC2 and cancer.